FDA Investigator Susan M Miller
Susan M Miller has conducted inspections on 219 sites in 3 countries as of 09 Jul 2018. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
219
Last Inspection Date:
09 Jul 2018
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Italy,
Spain
FDA Investigators that have inspected at least one site in common with Susan M Miller:
Aaron L Dunbar,
Abraham M Maekele,
Adam J Taylor,
Alecia L Marson,
Alexander M Kay,
Allison E Sincek,
Amanda B Vega,
Amir Alavi,
Andrew Saunders,
Anthony L Nicoli,
Barbara A Gullick,
Barbara D Wright,
Boun M Xiong,
Brentley S Collins,
Brian L Szcyubialka,
Camilla S Smith,
Carolyn A Warren,
Catherine M Vanderhoef,
Chantel D Stennis,
Charles M Spyr,
Charles R Cote, RIC,
Christina A Castineyra,
Christine M Erickson,
Christopher C Wilcox,
Conor J Mccarron,
Corey K Reno,
Courtney R Ingalsbe,
Dale A Nyberg,
Darlene L Krieger,
Delkis J Caycedo,
Demetria L Lueneburg,
Denise L Burosh,
Dennis R Hudson,
Diane T Reindl,
Don A Leeseberg,
Donald R Goldsmith,
Donna D Gallien, MPH,
Elizabeth A Laudig,
Elizabeth B Griffin,
Elizabeth E Hart (ASCP), MT,
Elizabeth P Mayer,
Ellen C Weisensel,
Emily S Mcgann,
Emmanuel A Dimaano, Jr,
Eric A Breselow,
Eric T Huebler,
Esther A Ofori,
Fannie M Harrell,
Gail L Katz,
Garrett W Steiner,
George T Allen, Jr,
Gerald Mierle,
Gerald T O'connor,
Gina M Scholze,
Gloria A Milster,
Grant M Ruis,
Gregory S Larson,
Gregory W Smith,
Hoimay Chan,
Howard A Burmester,
Ivan E Reyes,
Jaclyn N Munsch,
Jacob W Reynolds,
Jacqueline M Bowling,
Jamie R Thompson,
Jane E Nelson,
Janis R Armedoriz,
Jasjeet K Sekhon,
Jean A Finger,
Jean M Bosenbecker,
Jeanne F Broderick,
Jeffery A Hangartner,
Jeffrey A Sincek,
Jeffry A Bernhardt,
Jennifer A Longie Vollom,
Jennifer Guttuso,
Jesse P Romenesko,
Jessica L Barr,
Joel D Hustedt,
John A Iwen,
John P Hermann,
Jon C Polzine,
Joseph D Gong,
Joseph M Edwin,
Joshua S Hoeh,
Joyce B Watson,
Justin A Boyd,
Justin J Jafferis,
Kaarin M Slotte,
Kailas Nagaraj,
Karen M Labounty,
Karla J Youngberg,
Katherine A Clarke Girolamo,
Kathleen B Swat,
Kellie L Thommes, RN,
Kellie L Westerbuhr,
Kenneth A Libertoski,
Kevin L Torgerson,
Kimberly W Destromp,
Kip J Hanks,
La Tasham Gunter,
Lauren M Lilly, PhD,
Laurie A Haxel,
LCDR Ismael Olvera, IV,
LCDR Matthew J Morrison,
Lee Terry Moore,
Leonard Pesetsky,
Lewis K Antwi,
Linda V Weyer,
Lisa M Lopez,
Lori A Holmquist,
Luis A Carrion,
Mada A Tautges,
Marc A Jackson, Jr,
Margaret A Foster,
Margaret Torres Vazquez,
Maria E Treadwell,
Maricelys Mercado,
Marlene L Davis,
Mary E Baker Brown,
Maryann Ruff,
Matthew J Gretkierewicz,
Melanie C Voges,
Melissa D Kalik,
Melissa J Holz,
Michael A Blaine,
Michael C Ireland,
Michael E Cimaglio,
Michelle J Glembin,
Minerva Rogers,
Mohammed H Adam,
Myra K Casey,
Nicholas J Dubrovin,
Nicholas S Vasilakes,
Nicole C Shokatz,
Normica G Facey,
Paola E Lathrop,
Patrick J Campbell,
Paul A Licata,
Peter R Lenahan,
Peter T Erlandson,
Rachel T Evans,
Rafael A Kaup,
Rebecca L Mullikin,
Richard W Koller,
Robert E Davis,
Robert J Waldorf,
Robert M Tillman,
Ronald R Ruff,
Rterry Bolen,
Sandra A Hughes,
Sandra Sejdinovic,
Sarah A Palmer,
Sarah L Clark,
Sarah Nwandiuko,
Scott B Laufenberg,
Scott L Schenian,
Scotty L Hargrave,
Stephanie Mangigian, MS/OSH, RN,
Susan M North,
Tania E Vizcaino,
Tanya L Keigley,
Tara M Carolfi,
Tara M Humfeld,
Terri L Jones,
Theresa C Klaman,
Thomas S Donaldson,
Thomas W Garvin,
Toni S Sturgis,
Traci C Kelm,
Travis S Bradley,
Tyson J Eldridge Stedman,
William E Keer,
William F Lagud, Jr,
William P Fournier,
Zoey A Trombley
Susan M Miller's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| December, 2014 | FDA 483 Response | American Tissue Services Foundation - Form 483R, 2014-12-29 |
| December, 2014 | EIR | American Tissue Services Foundation - EIR, 2014-12-17 |
| June, 2011 | FDA 483 | Innovative Blood Resources - Form 483, 2011-06-17 |
| December, 2014 | FDA 483 | American Tissue Services Foundation - Form 483, 2014-12-17 |
| April, 2010 | FDA 483 | American National Red Cross (The) - Form 483, 2010-04-23 |
| February, 2013 | FDA 483 | CSL Plasma Inc. - Form 483, 2013-02-19 |
| February, 2013 | FDA 483 Response | CSL Plasma Inc. - Form 483R, 2013-02-28 |
| March, 2012 | FDA 483 | BloodCenter of Wisconsin Inc. Wisconsin Tissue Bank - Form 483, 2012-03-07 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more